Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease.

Mitsides, Nicos; Mitra, Vikram; Saha, Ananya; Harris, Shelly; Kalra, Philip A; Mitra, Sandip

Mitsides, Nicos; Mitra, Vikram; Saha, Ananya; Harris, Shelly; Kalra, Philip A; Mitra, Sandip.

Afiliação

Mitsides N; Medical School, University of Cyprus, 2029 Nicosia, Cyprus.
Mitra V; Department of Nephrology, Nicosia General Hospital, 2029 Nicosia, Cyprus.
Saha A; John Radcliffe Hospital, Oxford University Medical School, Headington, University of Oxford, Oxford OX1 2JD, UK.
Harris S; Manchester Institute of Nephrology and Transplantation, Department of Research and Innovation, Manchester University Hospitals, Manchester M13 9WL, UK.
Kalra PA; Manchester Institute of Nephrology and Transplantation, Department of Research and Innovation, Manchester University Hospitals, Manchester M13 9WL, UK.
Mitra S; Department of Renal Medicine, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Sciences Centre, Salford M6 8HD, UK.

J Pers Med ; 13(10)2023 Oct 11.

Article em En | MEDLINE | ID: mdl-37888092

Palavras-chave

biomarkers; chronic kidney disease; urinary liver-type fatty acid binding protein; urinary protein-to-creatinine ratio

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Pers Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Chipre

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google